Turn Out the Lights on iBio’s Covid-19 Vaccine Party

The race to develop a vaccine to fight the novel coronavirus is like any other competition. There are going to be winners and losers. It appears iBio (NYSEAMERICAN:IBIO) will be in the latter the camp despite the fact that IBIO stock is up 691% this year.